written on 30.05.2014
Tags:
,

FDA gives Genzyme/Sanofi MS drug Lemtrada 2nd look

TAGS: ,

Regulators told Genzyme it needed to complete one or more active comparator trials of different design and execution before the FDA would consider approving Lemtrada in MS.

Latest Report